Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Redini

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|January 19, 2016
Bone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaFrançoise Redini, Dominique Heymann
Drug Discovery Today|November 28, 2001
Osteoprotegerin: a new therapeutic agent for the treatment of bone diseaseEva Grimaud, Françoise Redini, Dominique Heymann
Future Oncology (London, England)|February 13, 2015
TRAIL-based therapy in pediatric bone tumors: how to overcome resistanceRomain Guiho, Kevin Biteau, Dominique Heymann, et al.
Expert Opinion on Pharmacotherapy|January 14, 2011
Mifamurtide for the treatment of nonmetastatic osteosarcomaKosei Ando, Kanji Mori, Nedège Corradini, et al.
Drug Discovery Today|June 18, 2010
Proteoglycans on bone tumor developmentCarmen Ruiz Velasco, Sylvia Colliec-Jouault, Françoise Redini, et al.
Expert Review of Anticancer Therapy|February 10, 2007
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategiesFrançois Lamoureux, Valérie Trichet, Céline Chipoy, et al.
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Journal of Clinical Medicine|November 10, 2016
TGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionAudrey Lamora, Julie Talbot, Mathilde Mullard, et al.
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 11, 2008
Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorptionBénédicte Brounais, Carmen Ruiz, Julie Rousseau, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|January 19, 2016
Bone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaFrançoise Redini, Dominique Heymann
Drug Discovery Today|November 28, 2001
Osteoprotegerin: a new therapeutic agent for the treatment of bone diseaseEva Grimaud, Françoise Redini, Dominique Heymann
Future Oncology (London, England)|February 13, 2015
TRAIL-based therapy in pediatric bone tumors: how to overcome resistanceRomain Guiho, Kevin Biteau, Dominique Heymann, et al.
Expert Opinion on Pharmacotherapy|January 14, 2011
Mifamurtide for the treatment of nonmetastatic osteosarcomaKosei Ando, Kanji Mori, Nedège Corradini, et al.
Drug Discovery Today|June 18, 2010
Proteoglycans on bone tumor developmentCarmen Ruiz Velasco, Sylvia Colliec-Jouault, Françoise Redini, et al.
Expert Review of Anticancer Therapy|February 10, 2007
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategiesFrançois Lamoureux, Valérie Trichet, Céline Chipoy, et al.
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Journal of Clinical Medicine|November 10, 2016
TGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionAudrey Lamora, Julie Talbot, Mathilde Mullard, et al.
Oncotarget|May 28, 2015
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesAudrey Lamora, Mathilde Mullard, Jérôme Amiaud, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 11, 2008
Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorptionBénédicte Brounais, Carmen Ruiz, Julie Rousseau, et al.
Pageof 5